We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Agrees To Suspend Sales Of Moexipril Pending Patent Suit Outcome

Law360 (September 13, 2004, 12:00 AM EDT) -- Israeli generics maker Teva Pharmaceutical Industries Ltd. has agreed to stop selling its generic version of Schwarz Pharma AG's Univasc hypertension drug until the resolution of a patent infringement lawsuit in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.